[Comparative effectiveness of different treatment methods of liver failure].
It was analyzed the results of treatment of 217 patients (139 men, 78 women) with chronic liver failure in case of liver cirrhosis of various etiology for study of degree of hepatic encephalopathyregression. All patients were divided into 3 groups. In the first group the drug therapy was used. In the second group additionallyplasma exchange was performed, in the third group - alsomolecular absorbent recirculating system was used (effectiveness of MARS-therapy).The results showed that the use of extracorporeal treatment techniques can effectively reduce the severity of hepatic encephalopathy in patients with liver cirrhosis. MARS-therapy improved the neurological status of patientsmore significantly in this case. It is considered that the inclusion of MARS-therapy in the combined treatment of patients leads to a significant reduction of hepatic encephalopathyseverity (1-2 points), in comparison with other methods of treatment.
D E
DE
Kutepov
M G
MG
Vershinina
I N
IN
Pasechnik
P S
PS
Sal'nikov
D057186:Comparative Effectiveness Research; D004151:Dipeptides / Q000627:therapeutic use; D005112:Extracorporeal Circulation / Q000379:methods; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000150:complications; D017093:Liver Failure / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D010951:Plasma Exchange / Q000379:methods*; D016060:Sorption Detoxification / Q000379:methods*; D016896:Treatment Outcome
D004151:Dipeptides; D005765:Gastrointestinal Agents; D007792:Lactulose; C002939:ornithylaspartate